Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers

21-11-2013 BMJ NewsComments (0)

Cardio-vascularPharmaceuticalUSA

The chairman and one of two additional co-chairs of the working panel that wrote the controversial cholesterol guidelines on reducing cardiovascular risk, released last week, had ties to the drug industry at the time they were asked to lead the panel. And, in all, eight of the 15 panelists had industry ties.

Read more on BMJ News

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top